New research finds gaps in charity care provided by 340B hospitals

The 340B program was created to support safety-net clinics and qualifying hospitals by establishing a discounted medicine program funded by biopharmaceutical manufacturers to help vulnerable patients access medicines. Unfortunately, the worst kept secret about the 340B program is the lack of clear patient benefit. There are zero patient protections and zero reporting requirements for covered entities to hold them accountable. Two recent pieces of research add to the mountain of evidence showing patients are not in fact benefiting from 340B when they seek care at 340B hospitals.
Source: The Catalyst - Category: Pharmaceuticals Tags: 340B Source Type: news